Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Projected CAGR for the Sarcopenia Treatment Market Size from 2025 to 2034?
The market size of sarcopenia treatment has been experiencing a robust expansion recently. A surge from $3.52 billion in 2024 to $3.72 billion in 2025 is projected, with a compound annual growth rate (CAGR) of 5.8%. Factors contributing to the historical growth include an aging population, awareness and diagnosis, lifestyle modifications, public health strategies, and regulatory approval.
In the forthcoming years, a robust expansion is anticipated in the size of the sarcopenia treatment market. The market is predicted to escalate to$4.69 billion by 2029 at a compound annual growth rate (CAGR) of 6.0%. Factors responsible for growth in the projected period include personalization of medicine, nutritional shifts, incorporation of digital health platforms, fostering patient knowledge and empowerment, alongside worldwide health initiatives. The forecast period is expected to witness trends like individualized treatments, the inception of new drug categories, integration of digital health, joint research ventures, and advancements in research and development.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13926&type=smp
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theSarcopenia Treatment Market?
The sarcopenia treatment market is expected to expand due to an increase in malnutrition. Malnutrition is a condition that includes deficiencies, excesses, or imbalances in a person’s consumption of energy and nutrients. It encompasses both undernutrition as well as overweight, obesity, and noncommunicable diseases related to diet. Sarcopenia treatment helps combat the parallel conditions of malnutrition and sarcopenia often seen in elderly people. It employs strategies like nutritional therapy and exercise to enhance muscle mass, strength, and overall nutritional health. For example, a report prepared by the World Health Organization (WHO), a United Nations (UN) agency based in Switzerland, in December 2023 revealed that malnutrition continues to be a major concern for global health. The report indicated that in 2022, there were an estimated 462 million underweight individuals and 149 million stunted children under the age of 5. Hence, this increase in malnutrition levels is fuelling the growth of the sarcopenia treatment market.
Which Segments in the Sarcopenia Treatment Offer the Most Growth?
The sarcopenia treatmentmarket covered in this report is segmented –
1) By Treatment Type: Protein Supplements; Vitamin B12 Supplements; Vitamin D And Calcium Supplements; Other Treatment Types
2) By Type: Primary Sarcopenia; Secondary Sarcopenia
3) By Route Of Administration: Oral; Parenteral; Enteral
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
Subsegments:
1) By Protein Supplements: Whey Protein; Casein Protein; Soy Protein; Plant-Based Protein
2) By Vitamin B12 Supplements: Cyanocobalamin; Methylcobalamin
3) By Vitamin D And Calcium Supplements: Vitamin D2; Vitamin D3; Calcium Carbonate; Calcium Citrate
4) By Other Treatment Types: Exercise Programs; Hormone Replacement Therapy; Other Nutritional Interventions
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13926&type=smp
What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theSarcopenia Treatment Market?# Market?
North America was the largest region in the sarcopenia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sarcopenia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Current Market Growth and Trends in the Sarcopenia Treatment Industry?
Prominent companies in the sarcopenia treatment market are ramping up their focus on the creation of advanced clinical study options for superior treatment avenues. Clinical studies represent systematic examinations performed on human participants in order to assess the safety, effectiveness, and outcomes of a respective medical procedure. Take for example Biophytis, a biotech firm based in France, which acquired the green light from the Food and Drug Administration (FDA) to commence the SARA-31 Phase 3 study for sarcopenia in September 2023. The goal of the study is to assess the safety and effectiveness of Sarconeos (BIO101) for the treatment of sarcopenic patients who face a risk of motor disability. This landmark study signals significant progress in both technological and pharmaceutical treatment strategies, potentially offering improved safety and effectiveness for those patients severely affected by sarcopenia. It holds the distinction of being the first Phase 3 study concerning sarcopenia to win FDA authorization. The study is set to involve approximately 900 sarcopenic patients aged 65 and above, who exhibit low walking speed and reduced hand grip strength. The main focus will be to evaluate the risk of major mobility disability (MMD), walking speed, hand grip strength, and the self-reported quality of life of patients.
View the full report here:
https://www.thebusinessresearchcompany.com/report/sarcopenia-treatment-global-market-report
What Are the Key Elements That Define the Sarcopenia Treatment Market?
Sarcopenia treatment refers to medical interventions and lifestyle approaches designed to counteract age-related muscle loss and maintain or improve skeletal muscle mass and function. The treatment is aimed at mitigating age-related muscle loss, improving muscle strength, and enhancing overall physical function and mobility.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13926
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model